AlphaMeld
AlphaMeld offers AI-powered tools to accelerate drug discovery and development. The AlphaMeld platform uses AI, machine learning, and generative AI to extract insights from petabytes of diverse data and generate testable hypotheses. It analyzes disease pathways, gene ontology, and therapeutic contexts to guide program design and selection. The product is a B2B platform used by pharmaceutical and biotech teams, often in collaboration with research spinouts. The market focus is AI-driven drug discovery for diseases with unmet medical needs, enabling faster, data-driven programs.
AlphaMeld
AlphaMeld offers AI-powered tools to accelerate drug discovery and development. The AlphaMeld platform uses AI, machine learning, and generative AI to extract insights from petabytes of diverse data and generate testable hypotheses. It analyzes disease pathways, gene ontology, and therapeutic contexts to guide program design and selection. The product is a B2B platform used by pharmaceutical and biotech teams, often in collaboration with research spinouts. The market focus is AI-driven drug discovery for diseases with unmet medical needs, enabling faster, data-driven programs.